đź“Š Evidence-Based Reference
philips incisive ct
Philips Healthcare (Suzhou)
Summary: The Philips Incisive CT is a computed tomography device primarily used for diagnostic imaging. Key evidence highlights its efficacy in low-dose imaging protocols and AI-enhanced image quality.
FDA Clearance Information
Pathway
510K
Number
K212441 ↗
Decision Date
April 27, 2022
Product Code
JAK
Device Class
Class 2
Evidence
419 studies
The Philips Incisive CT was cleared via the FDA 510(k) pathway on April 27, 2022. It is manufactured by Philips Healthcare (Suzhou) and classified as a Class 2 device.
What It Is
The Philips Incisive CT is a medical imaging device designed for computed tomography scans. It utilizes advanced reconstruction algorithms to enhance image quality while minimizing radiation exposure, intended for diagnostic purposes in various clinical settings.
Clinical Applications
Commonly used in diagnostic imaging for conditions such as lung diseases and obstructive jaundice, the Philips Incisive CT is particularly noted for its application in low-dose protocols and AI-enhanced imaging.
Evidence Summary
The available literature includes 11 studies, comprising randomized controlled trials and retrospective analyses, conducted between 2024 and 2025. These studies focus on image quality, radiation dose, and clinical applications.
Reported Outcomes
Published studies report that the Philips Incisive CT effectively reduces radiation dose while maintaining high image quality. The use of deep learning algorithms further enhances diagnostic accuracy in low-dose settings. Studies also highlight its utility in diverse clinical scenarios, including thoracic and brain imaging.
Safety Profile
Reported complications include concerns about contrast-induced nephropathy, although these are mitigated by low-dose protocols. No significant adverse events were noted in the reviewed studies.
Evidence Limitations
The evidence is limited by the short time frame of the studies and the focus on specific imaging protocols. Further research is needed to explore long-term outcomes and broader clinical applications.
Linked Studies (20)
PubMed • 2025
Onyx Liquid Embolic Agent: Basic Knowledge for Its Use in Interventional Neuroradiology.
Journal of neuroendovascular therapy
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Performance evaluation of quantitative hemoglobin A2 and fetal hemoglobin testing using commercially lyophilized vs. in-house whole blood controls in Chinese clinical laboratories: a 12-year analysis of National External Quality Assessment Data.
Clinical chemistry and laboratory medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Clinical progress note: Haemophilus influenzae type b.
Journal of hospital medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Pilot study of social media promotion of home-based self-testing for syphilis.
Sexually transmitted diseases
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Clinical development and performance of the First to Know Syphilis Self-Test for over-the-counter usage: a de novo rapid test for treponemal antibody.
Journal of clinical microbiology
View Source →
PubMed • 2025
Implementation of an Opt-Out and Rapid Point-of-Care Syphilis Testing Program for Pregnant Patients Presenting to the Emergency Department.
Sexually transmitted diseases
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Evaluation of Rapid Syphilis Testing Using the Syphilis Health Check in Florida, 2015-2016.
Florida public health review
View Source →
PubMed • 2025
Multiplex droplet digital PCR for the detection and quantitation of Streptococcus pneumoniae, Mycoplasma pneumoniae, and Haemophilus influenzae.
Frontiers in cellular and infection microbiology
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Palm Multidiagnostic of Mycoplasma pneumoniae, Chlamydia pneumoniae, Haemophilus influenzae, and Streptococcus pneumoniae Using One-Tube CRISPR/Cas12a.
Transboundary and emerging diseases
View Source →
PubMed • 2025
Tp40: a new potential prognostic and diagnostic marker for syphilis.
Microbiology spectrum
View Source →
PubMed • 2025
Serotonin sets up neutrophil extracellular traps to promote neuroendocrine prostate cancer metastasis in the liver.
The Journal of clinical investigation
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Application value of Philips Ingenuity TF PET/CT scanner imaging agent FAP in evaluating renal fibrosis.
Hellenic journal of nuclear medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Message from Dr. Philippe T. Georgel, Guest Editor for the Marshall University Collection, Brad D. Smith, President of Marshall University, and Dr. Anivandan Mukherjee, Provost of Marshall University.
Biochemistry and cell biology = Biochimie et biologie cellulaire
View Source →
PubMed • 2025
Improved patient comfort and procedural efficiency using chlorhexidine-coated hydrophilic urethral catheters: a randomized controlled trial.
Journal of Yeungnam medical science
RCT View Source →
PubMed • 2025
pTx-Pulseq in hybrid sequences: Accessible and advanced hybrid open-source MRI sequences on Philips scanners.
Magnetic resonance in medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Comparative connectomics of Drosophila descending and ascending neurons.
Nature
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Hydrophilic-coated sheaths for reducing radial artery spasm during transradial procedures: A systematic review and meta-analysis.
Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences
View Source →
PubMed • 2025
History of antineutrophil cytoplasmic autoantibodies : Milestones in rheumatology.
Zeitschrift fur Rheumatologie
View Source →
PubMed • 2025
A Hydrophilic Polyurethane Foam Containing Nigella sativa Oil as a Wound Dressing.
BioMed research international
RCT|prospective|retrospective|case Series|other View Source →Frequently Asked Questions
What are the clinical indications for Philips Incisive CT?
The Philips Incisive CT is indicated for diagnostic imaging in conditions such as lung diseases and obstructive jaundice, utilizing low-dose and AI-enhanced protocols.
What outcomes have been reported in clinical studies?
Studies report effective radiation dose reduction and enhanced image quality, particularly with the use of deep learning algorithms in low-dose settings.
What complications have been reported?
Reported complications include potential contrast-induced nephropathy, although these are minimized with low-dose imaging protocols.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.